StonvexLoading…
StonvexStonvexStonvexCore line items from LTRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $122.92M | $160.33M | $131.19M | $129.66M |
Operating Income | $-11.00M | $-2.86M | $-6.67M | $-5.01M |
Net Income | $-11.37M | $-4.52M | $-8.98M | $-5.36M |
EPS (Diluted) | $-0.29 | $-0.12 | $-0.25 | $-0.16 |
Total Assets | $123.72M | $136.21M | $151.62M | $137.37M |
Total Liabilities | $49.34M | $54.85M | $74.07M | $57.48M |
Cash & Equivalents | $20.10M | $26.24M | $13.45M | $17.22M |
Free Cash Flow OCF − CapEx | $6.78M | $17.14M | $-2.44M | $-11.53M |
Shares Outstanding | 39.10M | 37.87M | 36.88M | 35.13M |